Minerva Neurosciences (NERV) EPS (Basic) (2013 - 2026)
Minerva Neurosciences' (NERV) quarterly EPS (Basic) came in at -$0.74 in Q1 2026, down 48.77% YoY from -$1.44 in Q1 2025, and down 9.19% on a QoQ basis from -$0.67 in Q4 2025.
Powered by 
Analysis
Minerva Neurosciences (NERV) EPS (Basic) (2013 - 2026) Analysis & Trends
Minerva Neurosciences (NERV) has 14 years of EPS (Basic) data on file, last reported at -$0.74 in Q1 2026.
- Quarterly EPS (Basic) fell 48.77% year-over-year to -$0.74 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 (up 93.35% YoY) and the FY2025 annual result came in at -$13.45, up 12.72% from the prior year.
- EPS (Basic) fell to -$0.74 in Q1 2026, from -$0.67 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.43 in Q2 2025 to a low of -$17.77 in Q4 2022.
- A 5-year average of -$3.54 and a median of -$0.93 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) plunged 343.92% — and 2025, when it jumped 94.92%.
- Tracing NERV's EPS (Basic) over 5 years: stood at -$17.77 in 2022, then rose by 10.31% to -$15.94 in 2023, then gained by 16.81% to -$13.26 in 2024, then jumped by 94.92% to -$0.67 in 2025, then decreased by 9.19% to -$0.74 in 2026.
- The last three EPS (Basic) figures came in at -$0.74 (Q1 2026), -$0.67 (Q4 2025), and -$1.85 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Minerva Neurosciences | 207.37 Mn | 207.37 Mn | - | 0.36 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.36 |
| Mar 31, 2026 | -0.37 |
| Dec 31, 2025 | -0.52 |
| Sep 30, 2025 | -0.36 |
| Jun 30, 2025 | -0.43 |
| Mar 31, 2025 | -0.49 |
| Dec 31, 2024 | -0.57 |
| Sep 30, 2024 | -0.54 |
| Jun 30, 2024 | -0.78 |
| Mar 31, 2024 | -0.84 |
| Dec 31, 2023 | -1.05 |
| Sep 30, 2023 | -0.76 |
| Jun 30, 2023 | -0.75 |
| Mar 31, 2023 | -0.93 |
| Dec 31, 2022 | -0.89 |
| Sep 30, 2022 | -0.94 |
| Jun 30, 2022 | -1.29 |
| Mar 31, 2022 | -1.49 |
| Dec 31, 2021 | -4.00 |
| Sep 30, 2021 | -1.41 |